ArticleTuberculosis and respiratory diseases2019

The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma.

Jong Hyun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.